Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics

Curr Top Med Chem. 2020;20(31):2866-2877. doi: 10.2174/1568026620666200922113430.

Abstract

Since a μ-opioid receptor gene containing multiple exons has been identified, the variety of splice variants for μ-opioid receptors have been reported in various species. Amidino-TAPA and IBNtxA have been discovered as new analgesics with different pharmacological profiles from morphine. These new analgesics show a very potent analgesic effect but do not have dependence liability. Interestingly, these analgesics show the selectivity to the morphine-insensitive μ-opioid receptor splice variants. The splice variants, sensitive to these new analgesics but insensitive to morphine, may be a better molecular target to develop the analgesics without side effects.

Keywords: Amidino-TAPA; IBNtxA; Molecular target; Narcotic analgesics; Splice variant; μ-Opioid receptor.

Publication types

  • Review

MeSH terms

  • Alternative Splicing / drug effects
  • Alternative Splicing / genetics
  • Analgesics, Opioid / chemistry
  • Analgesics, Opioid / pharmacology*
  • Humans
  • Receptors, Opioid, mu / antagonists & inhibitors*
  • Receptors, Opioid, mu / genetics

Substances

  • Analgesics, Opioid
  • OPRM1 protein, human
  • Receptors, Opioid, mu